Bladder Cancer - Results from #60

The CAG-triplet in the androgen receptor gene and single-nucleotide polymorphisms in androgen pathway genes in patients with concomitant bladder and prostate cancer. April 20, 2022

Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity. April 20, 2022

An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials. April 20, 2022

Gene Signatures Predicting Recurrence and Progression of Bladder Cancer - Expert Commentary April 19, 2022

Evaluation of the Extent of Variant Histology in Urothelial Carcinoma as a Predictive Marker of Clinical Outcomes After Radical Cystectomy. April 19, 2022

Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study. April 19, 2022

Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer-A Narrative Review. April 19, 2022

Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer. April 19, 2022

Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. April 18, 2022

Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study. April 18, 2022

Single-Cell Transcriptomic Profiling of Bladder Cancer - Expert Commentary April 15, 2022

Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer. April 15, 2022

Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma. April 15, 2022

Single-Cell Transcriptome Comparison of Bladder Cancer Reveals Its Ecosystem. April 15, 2022

Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study: Pooled analysis of 12 international cohort studies. April 14, 2022

Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA. April 14, 2022

Hospital variation in treatment patterns and oncological outcomes for patients with muscle-invasive and metastatic bladder cancer in the Netherlands. April 13, 2022

Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial. April 13, 2022

Patient Outcomes After Concurrent Radical Cystectomy and Nephroureterectomy - Expert Commentary April 12, 2022

The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer. April 12, 2022

Page 4 of 428

email news signup